We've found
2,857
archived clinical trials in
Hot Flash
We've found
2,857
archived clinical trials in
Hot Flash
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
Updated: 12/31/1969
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
Updated: 12/31/1969
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
Updated: 12/31/1969
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
Updated: 12/31/1969
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
Updated: 12/31/1969
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
Updated: 12/31/1969
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
Updated: 12/31/1969
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
Updated: 12/31/1969
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
Updated: 12/31/1969
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
Updated: 12/31/1969
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
Updated: 12/31/1969
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
Updated: 12/31/1969
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
Updated: 12/31/1969
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
Updated: 12/31/1969
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Updated: 12/31/1969
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials